Is commercial control necessary as a third party internal control for HIV – antibody ELISA testing? A comparative study in NABL accredited laboratory
Journal Title: Indian Journal of Microbiology Research - Year 2017, Vol 4, Issue 2
Abstract
Aims & Objectives: To assess and compare the feasibility, availability, affordability, stability of In-house and commercial third party internal control of HIV antibody ELISA test. Methods: A comparative study was conducted in NABL Accredited Diagnostic Laboratory at Krishna Institute of Medical Sciences Karad during June 2014 to July 2016. Sample size includes total of 457 ELISA tests which were carried out on 11425 patients along with internal, external commercial and in-house control as per NACO guidelines. Descriptive and inferential statistical tests were applied to find out significant difference between in-house and commercial control. Results: There is significant difference in mean values of positive kit control and commercial positive control (p<0.05). There is also significant difference observed in mean values of commercial positive control and in-house positive control (p<0.05). The coefficient variance of positive in -house control is better (3.32) than commercial positive control (4.60) which indicates, in-house control is more precise than commercial control. The kit cut off values remains constant throughout the month indicates best technical competence, less environmental influences and reagent stability. The average cost of screening for HIV with ELISA and in-house control was Rs. 57/ per person. Conclusion: There is no significant difference in mean values of positive kit control and in-house positive control, the diagnostic cost, feasibility and percentage CV% is better observed in in-house control as compared to commercial control indicating in-house control could be considered as third party internal control for HIV antibody ELISA test.
Authors and Affiliations
RV Shinde, AR Shinde, ST Mohite, GS Karande
Keywords
Related Articles
- EP ID EP294268
- DOI 10.18231/2394-5478.2017.0030
- Views 108
- Downloads 0
Comparison of Phenotypic and molecular profile of Coagulase negative Staphylococci from clinical isolates and commensals along with Biofilm detection
Background: Coagulase-Negative Staphylococci (CoNS) are commensals of the human skin and mucosa. However, Staphylococcus epidermidis (S. epidermidis) and other CoNS have emerged as nosocomial pathogens. This study aims t...
Detection of methyltransferase CFR multidrug resistant gene in bacterial isolates from intensive care unit and ocular infections
We screened a total of 308 bacterial isolates (25 ICU and 283 ocular samples) for the presence of cfr gene and a mutation in the V-domain of 23S rRNA, as they are known to confer resistance to various antibiotics, includ...
“Clinicomycological study of Dermatomycosis in a tertiary care hospital”
Background: Dermatophytosis refers to superficial fungal infection of keratinized tissues caused by dermatophytes. Dermatophytes colonize only the cornified layer of epidermis or suprafollicular portions of hair and do n...
Operating theaters as a source of nosocomial infection in district hospital: A systematic review
Microbial contamination of operation theaters (OTs) is a major cause of nosocomial infections (NIs). Nosocomial infection is a main hassle in any healthcare facility. UTI, Surgical site infection, pneumonia and blood str...
Clinico-bacteriological study of pyoderma with special reference to methicillin resistant Staphylococcus aureus
Pyoderma is one of the common skin infections seen in dermatology clinics in India. The changing pattern of etiological agents of pyoderma and the emergence of antibiotic resistant strains are posing a significant proble...